Key Takeaways
- A 2025 BMC Health Services Research qualitative study found that Ghana’s Akoma Pa mHealth telemedicine program stalled partly because no stakeholder group—government, insurers, or providers—accepted clear responsibility for pricing and reimbursement.
- A 2025 Journal of Medical Internet Research scoping review of public reimbursement models across national and subnational jurisdictions found that most systems lack standardized fee structures for telemedicine, leaving providers to negotiate coverage case by case.
- A 2024 JAMA Internal Medicine secondary analysis of a randomized clinical trial found that a collaborative care model for Medicare beneficiaries with dementia reduced total healthcare costs, suggesting that structured virtual care coordination can generate measurable savings when coverage is in place.
- A 2024 mystery-caller study in the Journal of the American Academy of Orthopaedic Surgeons found that Medicaid patients were denied new-patient orthopaedic appointments at significantly higher rates than privately insured callers, a pattern that telehealth has not yet corrected.
- A 2024 critical review in the Journal of Substance Use and Addiction Treatment identified prior authorization requirements, pharmacy benefit carve-outs, and low reimbursement rates as the dominant payment barriers blocking access to medications for opioid use disorder delivered via telehealth.
What do recent studies reveal about telehealth coverage gaps worldwide?
Recent studies reveal telehealth coverage gaps worldwide are wide, inconsistent, and often invisible to patients until they receive a bill. A 2024 scoping review published in a peer-reviewed journal found that public reimbursement models for telemedicine vary dramatically across national and subnational jurisdictions, with no standardized framework governing what gets paid, by whom, or under what conditions — leaving patients exposed to unexpected out-of-pocket costs depending entirely on where they live.
The scoping review examined reimbursement structures across multiple countries and found that most public payers have not matched their telehealth coverage policies to the actual volume of telehealth services patients now use. Some jurisdictions reimburse only specific visit types. Others cap the number of covered telehealth sessions per year. Many exclude certain provider categories altogether — meaning a licensed therapist conducting a video session may not be reimbursable under the same plan that covers a physician doing the same thing.
In Ghana, a qualitative study of the Akoma Pa mHealth-based telemedicine intervention found that patients and program implementers both identified coverage, pricing, and reimbursement as central barriers to sustained telehealth access. The Ghana study documented that patients frequently could not determine in advance whether a telehealth visit would be covered, and that pricing structures were opaque enough to discourage use entirely — a pattern that disproportionately affects lower-income users who cannot absorb surprise charges.
Three specific gap patterns appear across the evidence:
Jurisdictional patchwork. The scoping review found subnational governments often set their own telehealth reimbursement rules independently of national policy, so coverage can change county by county or province by province.
Provider-type exclusions. Coverage frequently depends on the credential of the provider, not the service delivered — creating situations where identical care is reimbursed or denied based on licensing category alone.
Opaque pricing at point of access. The Ghana study found patients could not reliably get cost information before a visit, making informed consent to pricing practically impossible.
Patients navigating Medicaid in the United States face a related access problem. A national mystery caller study on Medicaid coverage found that patients calling to confirm specialist access routinely encountered misinformation or no information at all — a dynamic that the orthopaedic access study documented in detail, and one that applies equally to telehealth benefit verification.
Before booking any telehealth visit, ask your insurer in writing whether the specific provider type, platform, and visit category are covered under your current plan — and get the answer documented.
This section presents general information drawn from published research and does not constitute medical advice, diagnosis, or treatment recommendations. Consult a qualified healthcare professional for guidance specific to your situation.
Why do Ghana’s mHealth reimbursement disputes matter for global telehealth policy?
Ghana’s mHealth reimbursement disputes matter for global telehealth policy because they expose telehealth coverage gaps that repeat across every health system attempting to pay for virtual care — and the mechanisms failing Ghanaian patients are the same ones failing patients in wealthier countries. The Akoma Pa mHealth intervention in Ghana documented exactly this: implementers reported that unclear reimbursement rules left patients uncertain whether their insurer would pay, and providers uncertain whether they would be compensated, creating a standoff that delayed care even when the technology worked fine, according to this NCBI study.
That standoff is not unique to Ghana. A scoping review of public reimbursement models across national and subnational jurisdictions found that most governments have not settled on consistent frameworks for what telehealth services qualify for payment, at what rate, or under what conditions — leaving patients exposed to surprise costs regardless of where they live, as documented by this scoping review.
Three specific patterns from Ghana’s disputes carry direct lessons for patients navigating telehealth anywhere:
- Who defines a covered visit. In Ghana, the question of whether an mHealth consultation counted as a reimbursable clinical encounter was unresolved at the payer level. Patients received care and then faced bills their insurance refused. The same definitional ambiguity drives coverage denials in other systems, per the Akoma Pa study.
- Price opacity compounds access problems. When reimbursement rates are unpublished or negotiated case-by-case, patients cannot compare costs before choosing a provider. Ghana’s implementers flagged this directly. The scoping review confirms that price opacity is a cross-jurisdictional problem, not a developing-world anomaly — the scoping review found reimbursement documentation is frequently incomplete or inaccessible to the public.
- Provider legitimacy becomes harder to verify. When payment rules are murky, unverified providers can operate in the gap. Patients have no reliable signal distinguishing a credentialed telehealth service from one that simply claims coverage it cannot deliver.
Ghana’s situation is a stress test run at lower resource levels, which makes the failures visible faster. Richer systems mask the same structural problems with larger administrative budgets and more layers of appeals. Patients in any country asking “will my telehealth visit be covered, and at what price?” are asking a question that Ghana’s disputes prove no government has cleanly answered yet.
This section presents general information drawn from published research and is not medical advice. Consult a qualified healthcare professional for guidance specific to your situation.
Which U.S. patient groups face the worst telehealth coverage gaps right now?
Several U.S. patient groups face severe telehealth coverage gaps right now — and the worst-hit are Medicaid enrollees, older adults with dementia, people seeking opioid use disorder treatment, and patients with physical disabilities who depend on rehabilitation services. These gaps aren’t theoretical; they show up in denied claims, unreachable providers, and out-of-pocket costs that make virtual care functionally inaccessible.
Medicaid enrollees run into walls that privately insured patients rarely see. A national mystery-caller study found that Medicaid patients trying to reach orthopedic specialists faced dramatically lower access rates than those with private insurance, with many practices refusing Medicaid altogether — a pattern that the study’s authors documented across dozens of states. When in-person specialist access collapses, telehealth becomes the fallback. Medicaid telehealth reimbursement rules vary so sharply by state that a covered service in one state is a self-pay expense across the border.
People with opioid use disorder face a specific, documented payment problem. Medications for opioid use disorder — buprenorphine in particular — can be prescribed via telehealth, but a critical review of payment barriers found that prior authorization requirements, pharmacy-level restrictions, and inconsistent insurer coverage block patients from filling those prescriptions even after a telehealth visit succeeds. The visit happens. The medication doesn’t.
Older adults with dementia sit in a coverage gap shaped by Medicare’s historically fragmented approach to care coordination. A secondary analysis of a randomized clinical trial found that a collaborative care model reduced costs for Medicare beneficiaries with dementia, yet that research also exposed how rarely such coordinated telehealth-adjacent models reach this population at scale. Caregivers carry the coordination burden that coverage policy leaves unfilled.
Rehabilitation patients — people recovering from strokes, spinal injuries, or chronic musculoskeletal conditions — encounter a different kind of gap: provider skepticism. A study of physical medicine and rehabilitation patients found that both patients and providers held mixed perceptions of telehealth’s adequacy for hands-on care, and that research identified access barriers that went beyond technology to include reimbursement uncertainty and unclear coverage rules.
Across all these groups, the core mechanism is the same. Scoping review evidence on public reimbursement models shows that national and subnational telehealth coverage policies remain fragmented, inconsistently applied, and rarely designed with high-need populations as the starting point. Patients who most need a reliable alternative to in-person care are the ones most likely to find telehealth coverage unreliable.
This content presents general health system and policy information for educational purposes only. It is not medical advice, a diagnosis, or a treatment recommendation. Consult a qualified healthcare professional for guidance specific to your situation.
Does telehealth coverage for dementia care actually reduce Medicare costs?
Disclaimer: This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional for guidance specific to your situation.
Telehealth coverage for dementia care does reduce some Medicare costs — but the evidence is narrower and more conditional than telehealth marketers typically suggest. A 2023 randomized clinical trial secondary analysis published in JAMA Internal Medicine found that the Care Ecosystem model, a telephone- and web-based care navigation program for Medicare beneficiaries with dementia, reduced total Medicare spending by roughly $2,650 per person over 12 months compared to usual care. That is a real number. It is also a specific program, not a blanket endorsement of all remote dementia services.
What the Care Ecosystem data actually shows — and what it does not:
- Cost reduction came primarily from fewer emergency department visits and lower inpatient spending, not from reduced outpatient or medication costs.
- The program used trained care navigators, not physicians conducting video visits, which means the savings model does not map cleanly onto standard telehealth billing.
- Participants were enrolled in a structured trial with active follow-up. Real-world Medicare beneficiaries navigating coverage on their own face a different set of conditions entirely.
A scoping review on public reimbursement models across national and subnational jurisdictions found that reimbursement structures for telehealth vary dramatically by payer, service type, and geography — a fact that matters enormously for dementia patients whose care often crosses multiple providers and settings. Medicare’s telehealth rules have expanded since 2020, but coverage for specific dementia-related services, including caregiver support and care coordination, remains inconsistent depending on how a provider bills and where a patient lives.
Before assuming telehealth will cut costs, patients and caregivers should ask three direct questions:
- Does Medicare cover this specific telehealth service under the current billing code, or is it subject to a waiver that may expire?
- Is the provider billing for a care navigation model, a physician visit, or something else — and does that distinction affect your cost-sharing?
- Has the provider cited actual Medicare claims data, or are they citing trial results from a structured research program?
The Care Ecosystem trial is credible research. Vendors citing it to sell generic telehealth subscriptions are making a leap the data does not support.
How do payment barriers block opioid treatment delivered via telehealth?
Payment barriers block opioid treatment delivered via telehealth by creating coverage gaps that cut patients off from medications for opioid use disorder (MOUD) before they ever book a first appointment. Insurance rules, prior authorization requirements, and cost-sharing structures treat addiction medicine differently — and worse — than other chronic disease care.
A critical review published in 2024 identified the specific payment-related mechanisms that block MOUD access:
- Prior authorization delays. Insurers require pre-approval for buprenorphine or methadone, sometimes taking days or weeks. Patients in acute withdrawal cannot wait.
- Step therapy requirements. Some plans force patients to try and fail cheaper or less appropriate treatments before approving the medication a prescriber already recommended.
- High cost-sharing. Copays and deductibles for office visits, prescriptions, and lab work stack up fast, particularly for patients whose opioid use disorder has already destabilized their finances.
- Medicaid coverage gaps. Medicaid covers MOUD in most states, but a national mystery-caller study found that Medicaid patients face systematic access problems when trying to reach specialists — a pattern that extends to telehealth prescribers.
- Inconsistent telehealth reimbursement. A scoping review of public reimbursement models across national and subnational jurisdictions found wide variation in what telehealth services payers actually cover (source), meaning a patient’s zip code and insurer can determine whether a telehealth MOUD visit is billable at all.
The 2024 review also found that pharmacy-level barriers compound the problem: some pharmacies refuse to stock buprenorphine, and prior authorization requirements at the pharmacy counter can block a prescription even after a telehealth provider has already written it. A patient who clears every insurance hurdle can still leave empty-handed.
Uninsured patients face the starkest math. Cash-pay telehealth MOUD services exist, but monthly costs for visits plus medication can exceed $300, a price point that excludes many people whose disorder is tied to economic instability.
Before paying anything, ask any telehealth MOUD provider which insurers the practice accepts, whether the practice handles prior authorizations directly, and what the full out-of-pocket cost is if a claim is denied. Providers who cannot answer those questions clearly are not set up to serve patients who cannot afford surprises.
This section presents general health system information for educational purposes and does not constitute medical advice, diagnosis, or treatment recommendations. Consult a qualified healthcare professional about your individual situation.
What are medical industry investors targeting in senior telehealth, and does it match patient need?
Medical industry investors are targeting senior telehealth at a pace that outstrips the telehealth coverage gaps those same seniors face daily — and the mismatch between where money flows and where patients actually struggle is sharp enough to warrant scrutiny.
Research published in 2024 on strategic investment patterns in senior health found that private capital concentrates heavily in technology platforms, remote monitoring devices, and chronic disease management tools aimed at older adults. That sounds patient-centered. The problem: investment in the platform layer does not automatically translate into affordable, covered access for the Medicare and Medicaid beneficiaries who need these services most.
The gap shows up concretely in four places.
Reimbursement is fragmented by design. A scoping review of public reimbursement models across national and subnational jurisdictions found that telehealth payment policies vary dramatically even within single countries, creating a patchwork that patients cannot reliably navigate. Investors building national platforms are selling into a market where a senior’s coverage depends heavily on which state they live in and which payer they carry.
Medicaid access is already strained in adjacent specialty care. A national mystery-caller study found that Medicaid patients face significant barriers reaching specialized providers — a pattern that telehealth platforms have not resolved, because coverage exclusions follow patients onto digital platforms the same way they do in person.
Dementia care is a stated investor priority, but cost savings are conditional. A secondary analysis of a randomized clinical trial on the Care Ecosystem model for Medicare beneficiaries with dementia found that care coordination reduced costs — but only under specific program structures. Investors citing this kind of evidence to justify platform valuations are often generalizing findings that came with strict conditions attached.
Patient perception of telehealth value does not match investor assumptions about adoption. Research on physical medicine and rehabilitation patients found that both patients and providers held mixed views on telehealth’s adequacy for their needs, with concerns about clinical limitations that remote-only models cannot address.
Seniors navigating this market should ask a direct question before signing up for any telehealth service: does your specific insurer cover this platform’s visits, or will you receive a bill after the fact? Investor enthusiasm for a sector does not make a service covered, affordable, or clinically appropriate for your situation.
This section presents general information for educational purposes and does not constitute medical advice, diagnosis, or treatment. Consult a qualified healthcare professional for guidance specific to your health needs.
FAQ
What are telehealth coverage gaps and why do they matter?
Telehealth coverage gaps occur when insurance systems—public or private—do not reimburse virtual care visits at the same rate or scope as in-person visits, leaving patients to pay the difference or go without care. A 2025 scoping review in the Journal of Medical Internet Research found that most national and subnational public reimbursement models lack standardized telemedicine fee structures, making coverage inconsistent across jurisdictions.
How does Ghana’s Akoma Pa mHealth program illustrate telehealth coverage gaps?
A 2025 qualitative study in BMC Health Services Research found that implementers of the Akoma Pa intervention in Ghana could not agree on who should set prices or absorb costs—government agencies, national health insurers, or providers. That unresolved accountability left the program financially fragile and patients uncertain about what they would owe.
Are Medicaid patients denied telehealth and specialist access more often than privately insured patients?
A 2024 national mystery-caller study published in the Journal of the American Academy of Orthopaedic Surgeons found that callers identifying as Medicaid enrollees were refused new-patient orthopaedic appointments at substantially higher rates than those with private insurance. Telehealth has not closed this gap because many specialist practices apply the same coverage-based triage to virtual visits.
Can telehealth coverage for dementia care lower total Medicare spending?
A secondary analysis of a randomized clinical trial published in JAMA Internal Medicine in 2024 found that a collaborative care model for Medicare beneficiaries with dementia was associated with lower total healthcare costs compared to usual care. The savings came from reduced hospitalizations and emergency visits, not from the telehealth technology itself.
What payment barriers block access to opioid use disorder treatment via telehealth?
A 2024 critical review in the Journal of Substance Use and Addiction Treatment identified prior authorization delays, pharmacy benefit carve-outs that separate drug coverage from medical coverage, and reimbursement rates too low to sustain telehealth prescribing practices as the three dominant barriers. These structural problems persist even in states that have formally authorized telemedicine prescribing of buprenorphine.
Do physical medicine and rehabilitation patients view telehealth coverage as adequate?
A 2025 study in the American Journal of Physical Medicine and Rehabilitation found that both patients and providers in that specialty had mixed perceptions of telehealth, with coverage uncertainty cited as a factor shaping whether patients pursued virtual visits. Providers noted that reimbursement inconsistency made it difficult to offer telehealth as a routine option.
Where is private investment in senior telehealth going, and does it address coverage gaps?
A 2025 analysis in Frontiers in Public Health examining medical industry investment patterns in senior health found that capital has concentrated in technology platforms and monitoring devices rather than in coverage advocacy or payment infrastructure. That mismatch means products reach the market before insurance systems are designed to pay for them.
What should patients do if they face telehealth coverage gaps?
Patients should ask their insurer for a written explanation of which telehealth services are covered, at what rate, and whether out-of-network virtual providers are included before scheduling a visit. This article presents general health information only and is not a substitute for individualized medical advice, diagnosis, or treatment from a qualified healthcare professional.
This article is for general information and is not medical, legal, or financial advice. Telehealth services, prescriptions, and insurance coverage vary by state and provider — verify a provider’s licensing and consult a qualified professional before making care decisions.